Johannes Kratz, MD
Associate Professor
Surgery
School of Medicine
johannes.kratz@ucsf.edu 415-353-7502
Johannes R. Kratz, M.D. is Medical Director of Robotic Surgery at UCSF and the Director of Minimally Invasive and Robotic Thoracic Surgery. Kratz graduated magna cum laude from Harvard Medical School and holds a Masters in Philosophy from Stanford.
Show full bio (210 words) Hide full bio
Kratz worked as research fellow in the Thoracic Oncology Lab from 2008-2011 where he played a pivotal role in the development of a prognostic assay for early-stage lung cancer patients. The novel assay was validated in an international clinical trial led by thoracic surgeons David M. Jablons, M.D. and Michael Mann, M.D. The assay better predicted risk of death in early-stage lung cancer patients versus conventional staging guidelines and later successfully identified Stage 1A lung cancer patients who had a very high likelihood of mortality after surgery. Kratz finished his clinical training as a clinical fellow in Thoracic Surgery at UCSF from 2014 - 2017 and subsequently joined the faculty.
Kratz holds the Van Auken Endowed Chair in Thoracic Oncology. He has been the recipient of numerous awards and honors including the UCSF Health Exceptional Physician Award, Hellman Family Clinical-Translational Research Development Award, Michael DeBakey Research Scholarship, Cardiothoracic Surgery Faculty Teaching Award, Haile T. Debas Academy of Medical Educators Excellence in Teaching Award, Partners Healthcare Teaching Award, Willard M. Daggett Award, Edward Churchill Surgical Research Fellowship, Wyeth Scholarship of the American College of Surgeons, John E. Thayer Scholarship Award, Howard Hughes Medical Fellows Program Continued Support Award, and designation as a Soma Weiss Scholar.
Awards
Show all (16) Hide
- Haile T. Debas Academy of Medical Educators Excellence in Teaching Award, University of California, San Francisco, 2023
- Cardiothoracic Surgery Faculty Teaching Award, University of California, San Francisco, 2021
- Michael DeBakey Research Scholarship, American Association for Thoracic Surgery, 2019
- Hellman Family Clinical-Translational Research Development Award, Bakar ImmunoX Initiative, 2019
- Haile T. Debas Academy of Medical Educators Excellence in Teaching Award, University of California, San Francisco, 2019
- Van Auken Endowed Chair in Thoracic Oncology, University of California, San Francisco, 2018
- UCSF Health Exceptional Physician Award, University of California, San Francisco, 2017
- First Place, Oral Presentation, Harvard Medical School Surgery Research Conference, Harvard Medical School, 2012
- Partners HealthCare Resident/Fellow as Teacher Award, Partners HealthCare, 2012
- President's Conference Selection, World Conference on Lung Cancer, International Association for the Study of Lung Cancer, 2011
- Willard M. Daggett Award, Massachusetts General Hospital, 2010
- Wyeth Scholarship of the American College of Surgeons for the Study of Inflammation, Massachusetts General Hospital, 2008
- Aesculapian Club, Harvard Medical School, 2006
- John E. Thayer Scholarship Award, Harvard Medical School, 2006
- Soma Weiss Scholar Award, Harvard Medical School, 2005
- Howard Hughes Research Training Fellowship, Harvard Medical School, 2004
Education & Training
Show all (7) Hide
- Diversity, Equity, and Inclusion Champion Training University of California 2019
- Fellowship Cardiothoracic Surgery University of California 2017
- Residency General Surgery Massachusetts General Hospital 2014
- M.D. (Magna Cum Laude) Harvard Medical School 2006
- M.A. Philosophy Stanford University 2000
- B.S. (with Honors with Distinction) Biological Sciences Stanford University 1999
- B.A. (with Distinction) Philosophy Stanford University 1999
Interests
Show all (8) Hide
- Esophageal Cancer
- Prognostic Biomarkers
- Predictive Biomarkers
- Thoracic Surgery
- Lung Cancer
- Thoracic Oncology
- Thymic Cancer
- Tumor Immunology
Websites
Show all (1) Hide
- Kratz Lab (kratzlab.ucsf.edu)
Videos
Show all (1) Hide
- Personalized Therapy for Early-Stage Lung Cancer at UCSF (medconnection.ucsfhealth.org)
Grants and Projects
Show all (4) Hide
- Immune Phenotypes of High-Risk Early Stage Lung Adenocarcinoma, American Association of Thoracic Surgery, 2020-2022
- CoProject Pilot in Early-Stage Lung Cancer, Bakar ImmunoX Foundation, 2019-2021
- COVID-19 Related Rapid Research Pilot Initiative, University of California, San Francisco, 2020-2021
- Lung Cancer Tumor Immune Microenvironments, Helen Diller Family Comprehensive Cancer Center, 2019-2020
Publications (76)
Top publication keywords:
Lung NeoplasmsGenes, NeoplasmBiomarkers, TumorMolecular Diagnostic TechniquesPancoast SyndromeCarcinoma, Large CellPostoperative ComplicationsElective Surgical ProceduresPolymerase Chain ReactionPulmonary Surgical ProceduresCarcinoma, Non-Small-Cell LungNeoplasm StagingTime-to-TreatmentCoronary AneurysmSurgical Procedures, Operative
-
Perioperative Lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program.
Annals of surgery 2021 Haro GJ, Sheu B, Marcus SG, Sarin A, Campbell L, Jablons DM, Kratz JR -
Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer.
JAMA network open 2019 Haro GJ, Sheu B, Cook NR, Woodard GA, Mann MJ, Kratz JR -
Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Kratz JR, Haro GJ, Cook NR, He J, Van Den Eeden SK, Woodard GA, Gubens MA, Jahan TM, Jones KD, Kim IJ, He B, Jablons DM, Mann MJ -
Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.
Clinical lung cancer 2017 Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM -
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.
JAMA 2012 Kratz JR, Van den Eeden SK, He J, Jablons DM, Mann MJ -
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.
Lancet (London, England) 2012 Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, Mulvihill MS, Ziaei F, Zhang H, Su B, Zhi X, Quesenberry CP, Habel LA, Deng Q, Wang Z, Zhou J, Li H, Huang MC, Yeh CC, Segal MR, Ray MR, Jones… -
Genomic prognostic models in early-stage lung cancer.
Clinical lung cancer 2009 Kratz JR, Jablons DM -
Catalysis of peptide dissociation from class II MHC-peptide complexes.
Proceedings of the National Academy of Sciences of the United States of America 1999 Schmitt L, Kratz JR, Davis MM, McConnell HM
Show all (68 more) Hide
-
Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.
Journal of Clinical Oncology 2024 Sofia Diana Merajver, Aaron M Udager, Angel Qin, Kiran Lagisetty, Liwei Bao, Xu Cheng, Hamadi Madhi, Laura Goo, Varun Kathawate, Peter Ulintz, Albert Liu, Habib Serhan, Vishal Navani, John L. … -
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 Blakely CM, Urisman A, Gubens MA, Mulvey CK, Allen GM, Shiboski SC, Rotow JK, Chakrabarti T, Kerr DL, Aredo JV, Bacaltos B, Gee M, Tan L, Jones KD, Devine WP, Doebele RC, Aisner DL, Patil T, Schenk EL… -
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
The Lancet. Digital health 2024 NIHR Global Health Research Unit on Global Surgery, STARSurg Collaborative -
Trans-Sternal Multilevel Corpectomy for Cervicothoracic Renal Cell Metastasis: 2-Dimensional Operative Video.
Operative neurosurgery (Hagerstown, Md.) 2024 Tawil ME, Chryssikos T, Sorour O, Ambati VS, Jamieson A, Theologis AA, Kratz J, Mummaneni PV -
Quantitative Polymerase Chain Reaction and Precision Medicine.
Advances in Medical Imaging, Detection, and Diagnosis 2023 Joel L. Ramirez, Johannes R. Kratz -
Treatments for dengue: a Global Dengue Alliance to address unmet needs.
The Lancet. Global health 2023 Dengue Alliance. Electronic address: gnmalavige@dndi.org, Dengue Alliance -
PET Standardized Uptake Value May Influence Surgical Planning for Clinical Stage IA Non-Small Cell Lung Cancer.
The Annals of thoracic surgery 2023 Murillo AD, Kratz JR -
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR -mutated non-small cell lung cancer.
Journal of Clinical Oncology 2023 Jacqueline V. Aredo, Anatoly Urisman, Matthew A. Gubens, Claire Mulvey, Greg M. Allen, Julia K. Rotow, Daniel Lucas Kerr, Turja Chakrabarti, Bianca Bacaltos, Megan Gee, Kirk Jones, Dara L. Aisner, … -
Transcriptional space-time mapping identifies concerted immune and stromal cell patterns and gene programs in wound healing and cancer.
Cell stem cell 2023 Hu KH, Kuhn NF, Courau T, Tsui J, Samad B, Ha P, Kratz JR, Combes AJ, Krummel MF -
287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers.
Journal of Clinical and Translational Science 2023 P. Jonathan Li, Jessica Tsui, Vivianne W. Ding, Alexis J. Combes, Matthew F. Krummel, David M. Jablons, Johannes R. Kratz -
Comparative genomics between matched solid and lepidic portions of semi-solid lung adenocarcinomas.
Lung cancer (Amsterdam, Netherlands) 2023 Woodard GA, Ding V, Cho C, Brand NR, Kratz JR, Jones KD, Jablons DM -
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants.
Stem cell reports 2023 Hysenaj L, Little S, Kulhanek K, Magnen M, Bahl K, Gbenedio OM, Prinz M, Rodriguez L, Andersen C, Rao AA, Shen A, Lone JC, Lupin-Jimenez LC, Bonser LR, Serwas NK, Mick E, Khalid MM, Taha TY, Kumar R, … -
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study.
American journal of obstetrics and gynecology 2022 Fotopoulou C, Khan T, Bracinik J, Glasbey J, Abu-Rustum N, Chiva L, Fagotti A, Fujiwara K, Ghebre R, Gutelkin M, Konney TO, Ng J, Pareja R, Kottayasamy Seenivasagam R, Sehouli J, Surappa STS, Bhangu A… -
Discovering dominant tumor immune archetypes in a pan-cancer census.
Cell 2021 Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, … -
Genetic and immunologic features of recurrent stage I lung adenocarcinoma.
Scientific reports 2021 Kratz JR, Li JZ, Tsui J, Lee JC, Ding VW, Rao AA, Mann MJ, Chan V, Combes AJ, Krummel MF, Jablons DM -
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
The British journal of surgery 2021 STARSurg Collaborative and COVIDSurg Collaborative -
Multiomic Characterization of Stage I Lung Adenocarcinoma Reveals Distinct Genetic and Immunologic Features of Recurrent Disease.
Journal of the American College of Surgeons 2021 Jack Z. Li, Vivianne W. Ding, David M. Jablons, Johannes R. Kratz -
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
The Lancet. Oncology 2021 COVIDSurg Collaborative -
P26.02 A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results.
Journal of Thoracic Oncology 2021 C. Blakely, A. Urisman, D. Kerr, W. Wu, B. Bacaltos, J. Rotow, M. Gubens, K. Jones, T. Bivona, S. Joo, J. Riess, D. Aisner, R. Doebele, T. Patil, E. Schenk, J. Kratz, D. Jablons -
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
The British journal of surgery 2021 COVIDSurg Collaborative, GlobalSurg Collaborative -
Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay.
Future oncology (London, England) 2021 Gupta AR, Woodard GA, Jablons DM, Mann MJ, Kratz JR -
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Anaesthesia 2021 COVIDSurg Collaborative, GlobalSurg Collaborative -
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy.
Clinical lung cancer 2021 Woodard GA, Kratz JR, Haro G, Gubens MA, Blakely CM, Jones KD, Mann MJ, Jablons DM -
SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator.
bioRxiv : the preprint server for biology 2021 Hysenaj L, Little S, Kulhanek K, Gbenedio OM, Rodriguez L, Shen A, Lone JC, Lupin-Jimenez LC, Bonser LR, Serwas NK, Bahl K, Mick E, Li JZ, Ding VW, Matsumoto S, Maishan M, Simoneau C, Fragiadakis G, … -
Resectability, Recurrence, and Risk Stratification of Giant Solitary Fibrous Tumors in the Thoracic Cavity.
Annals of surgical oncology 2021 Woodard GA, Fels Elliott DR, Yap A, Haro GJ, Kratz JR, Mann MJ, Jones KD, Jablons DM -
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Anaesthesia 2021 COVIDSurg Collaborative, GlobalSurg Collaborative -
Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models.
Cancers 2021 Li PJ, Roose JP, Jablons DM, Kratz JR -
Commentary: Cardiothoracic surgery training: Global challenges without universal solutions.
The Journal of thoracic and cardiovascular surgery 2021 Kratz JR, Nguyen TC -
MO01.13 Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit from Adjuvant Chemotherapy.
Journal of Thoracic Oncology 2021 G. Woodard, J. Kratz, G. Haro, M. Gubens, C. Blakely, K. Jones, M. Mann, D. Jablons -
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, … -
Delaying surgery for patients with a previous SARS-CoV-2 infection.
The British journal of surgery 2020 COVIDSurg Collaborative -
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.
Cell 2020 Maynard A, McCoach CE, Rotow JK, Harris L, Haderk F, Kerr DL, Yu EA, Schenk EL, Tan W, Zee A, Tan M, Gui P, Lea T, Wu W, Urisman A, Jones K, Sit R, Kolli PK, Seeley E, Gesthalter Y, Le DD, Yamauchi KA… -
Pulmonary Embolus of Benign Liver Tissue Following Partial Hepatectomy.
AJSP Review and Reports 2020 Calixto-Hope G. Lucas, Johannes R. Kratz, Anatoly Urisman -
Esophagectomy Outcomes after Implementation of an Enhanced Recovery after Surgery Program.
Journal of the American College of Surgeons 2019 Greg J. Haro, Fang Yu Sheu, Stanley J. Rogers, David M. Jablons, Johannes R. Kratz -
MA06.09 Timing of Driver Mutation Development and the Genetic Evolution of Semi-Solid Lung Nodules into Early NSCLC.
Journal of Thoracic Oncology 2019 G. Woodard, V. Ding, I. Kim, K. Jones, G. Chavez, G. Haro, J. Kratz, M. Mann, J. Rotow, C. Blakely, D. Jablons -
P1.14-58 A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer.
Journal of Thoracic Oncology 2019 J. Rotow, A. Urisman, C. Mccoach, T. Jahan, T. Bivona, K. Jones, A. Gupta, H. Do, J. Riess, D. Aisner, R. Doebele, D. Jablons, J. Kratz, C. Blakely -
Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma.
Cancer management and research 2019 Jiang L, Tolani B, Yeh CC, Fan Y, Reza JA, Horvai AE, Xia E, Kratz JR, Jablons DM, Mann MJ -
Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
Genetic testing and molecular biomarkers 2019 Lancaster EM, Jablons D, Kratz JR -
Quantitative Polymerase Chain Reaction for Companion Diagnostics and Precision Medicine Application.
2019 Joel L Ramirez, Johannes R Kratz -
Central Airway Obstruction Due to Tracheal Glomus Tumor.
The Thoracic and cardiovascular surgeon reports 2018 Haro GJ, Seeley EJ, Jablons DM, Kratz JR -
Giant right coronary artery aneurysm presenting as cardiac tamponade.
Interactive cardiovascular and thoracic surgery 2018 Ramirez JL, Kratz JR, Wieselthaler GM -
P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit from Adjuvant Chemotherapy.
Journal of Thoracic Oncology 2018 G. Woodard, S. Wang, J. Kratz, G. Haro, M. Gubens, C. Blakely, T. Jahan, K. Jones, M. Mann, D. Jablons -
P3.03-24 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.
Journal of Thoracic Oncology 2018 G. Haro, J. Kratz, N. Cook, J. He, S. Van Den Eeden, G. Woodard, M. Gubens, T. Jahan, K. Jones, I. Kim, B. He, D. Jablons, M. Mann -
Propensity Matched Analysis of Perioperative Outcomes in Robotic-Assisted Thoracic Surgery, Video Assisted Thoracic Surgery, and Open Lung Resections.
Journal of the American College of Surgeons 2018 Greg J. Haro, Johannes R. Kratz, David M. Jablons, Michael J. Mann, Jasleen Kukreja -
Intraoperative identification and treatment of a giant right coronary artery aneurysm.
Multimedia manual of cardiothoracic surgery : MMCTS 2018 Ramirez J, Wieselthaler G, Kratz J -
Surgical Management of Pulmonary Mucormycosis in Third-Trimester Pregnancy.
The Thoracic and cardiovascular surgeon reports 2018 Ramirez JL, Urisman A, Kukreja J, Kratz JR -
Management of Lung Cancer Invading the Superior Sulcus.
Thoracic surgery clinics 2017 Kratz JR, Woodard G, Jablons DM -
OA19.06 Adjuvant Chemotherapy Decisions Based on Molecular Risk Status Improves Outcomes in Early Stage, Non-Small Cell Lung Cancer.
Journal of Thoracic Oncology 2017 Gavitt Woodard, Jane Crockard, Clara Zoon-Besselink, Johannes Kratz, Matthew Gubens, Thierry Jahan, Collin Blakely, Kirk Jones, Michael Mann, David Jablons -
P1.03-066 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer TNM Staging Topic: Staging.
Journal of Thoracic Oncology 2017 Johannes Kratz, Nancy Cook, Gavitt Woodard, Kirk Jones, Matthew Gubens, Thierry Jahan, Il-Jin Kim, Biao He, David Jablons, Michael Mann -
High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.
Annals of hepatology 2016 Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA -
High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.
Annals of hepatology 2016 Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA -
Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.
Oncology reports 2015 Hirata T, Zheng Q, Chen Z, Kinoshita H, Okamoto J, Kratz J, Li H, Lui N, Do H, Cheng T, Tseng HH, Koizumi K, Shimizu K, Zhou HM, Jablons D, He B -
The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
Journal of the American College of Surgeons 2015 Patel MS, Kohn R, Kratz JR, Shah JA, Markmann JF, Vagefi PA -
Prognostic and Predictive Biomarker Signatures.
Lung Cancer 2014 Johannes R. Kratz, David M. Jablons -
The migrated liver transplantation candidate: insight into geographic disparities in liver distribution.
Journal of the American College of Surgeons 2014 Kohn R, Kratz JR, Markmann JF, Vagefi PA -
Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2013 Kratz JR, Tham PT, Mulvihill MS, Ziaei F, Ray MR, Hurst JW, Segal MR, Berryman DM, Chu W, He B, Jablons DM, Mann MJ -
International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature.
Translational lung cancer research 2013 Kratz JR, Mann MJ, Jablons DM -
Prognostic assay in small, node-negative non-small cell lung cancer--reply.
JAMA 2013 Mann MJ, Jablons DM, Kratz JR -
The role of stem cells in airway repair: implications for the origins of lung cancer.
Chinese journal of cancer 2012 Mulvihill MS, Kratz JR, Pham P, Jablons DM, He B -
Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
International journal of oncology 2012 Choi H, Kratz J, Pham P, Lee S, Ray R, Kwon YW, Mao JH, Kang HC, Jablons D, Kim IJ -
IL11 is prognostic of survival in lung adenocarcinoma.
Journal of the American College of Surgeons 2011 Johannes R. Kratz, Patrick T. Pham, Michael S. Mulvihill, M. Roshni Ray, Michael J. Mann, David M. Jablons -
Child neurology: Brachial plexus birth injury: what every neurologist needs to know.
Neurology 2011 Pham CB, Kratz JR, Jelin AC, Gelfand AA -
Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.
Clinical lung cancer 2011 Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, Segal M, Chen Z, Zhou HM, Pham P, Li H, Yagui-Beltran A, Beltran A, Ray MR, Koizumi K, Shimizu K, Jablons D, He B -
Cancer stem cells in lung tumorigenesis.
The Annals of thoracic surgery 2010 Kratz JR, Yagui-Beltrán A, Jablons DM -
Anal canal duplication associated with presacral cyst.
Journal of pediatric surgery 2008 Kratz JR, Deshpande V, Ryan DP, Goldstein AM -
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2.
The Journal of clinical investigation 2005 Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA, García-Cardeña G -
Fluid Mechanical Forces as Extrinsic Modifiers of Endothelial Function.
Endothelial Cells in Health and Disease 2005 Johannes Kratz, Kush Parmar, Sripriya Natarajan, Guillermo García-Cardeña -
Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site.
The Journal of thoracic and cardiovascular surgery 2004 Rabkin-Aikawa E, Aikawa M, Farber M, Kratz JR, Garcia-Cardena G, Kouchoukos NT, Mitchell MB, Jonas RA, Schoen FJ